TIDMGSK

RNS Number : 7993P

GlaxoSmithKline PLC

12 February 2019

GlaxoSmithKline plc (the 'Company')

Conditional Share Awards and Shares withheld or sold to meet tax liabilities

This notification sets out the details of the vesting of awards and the sale or withholding of shares to meet tax liabilities over Ordinary Shares made in 2016 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group. The restricted period for the 2016 SVP awards has now ended and the awards made to Persons Discharging Managerial Responsibility (PDMRs) vested on 11 February 2019.

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     =================================================================== 
 a)   Name                      Mr J Ford 
===  =========================  ======================================== 
 b)   Position/status           SVP & General Counsel 
===  =========================  ======================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  ======================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  ======================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  ======================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =================================================================== 
 a)   Description of             American Depositary Shares ('ADSs') 
       the financial 
       instrument                 ISIN: US37733W1053 
===  =========================  ======================================== 
 b)   Nature of the             The vesting and release of ADSs awarded 
       transaction               in 2016 under the Company's 2009 Share 
                                 Value Plan. 
===  =========================  ======================================== 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                              ---------- 
                                   n/a 
                                    .          6,320 
                                              ---------- 
===  =========================  ======================================== 
 d)   Aggregated information    n/a (single transaction) 
       Aggregated volume 
       Price 
===  =========================  ======================================== 
 e)   Date of the transaction   2019-02-11 
===  =========================  ======================================== 
 f)   Place of the              New York Stock Exchange (XNYS) 
       transaction 
===  =========================  ======================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ==================================================================== 
 a)   Name                     Mr J Ford 
===  ========================  ========================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  ========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ==================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ==================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial 
       instrument                ISIN: US37733W1053 
===  ========================  ========================================== 
 b)   Nature of the            The sale of ADSs to meet tax liabilities 
       transaction              further to the vesting and release of the 
                                2016 award under the Company's 2009 Share 
                                Value Plan. 
===  ========================  ========================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                            ---------- 
                                  $40.2654   3,113 
                                   . 
                                            ---------- 
===  ========================  ========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ========================================== 
 e)   Date of the transaction  2019-02-11 
===  ========================  ========================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     =================================================================== 
 a)   Name                      Mr B McNamara 
===  =========================  ======================================== 
 b)   Position/status           CEO, GSK Consumer Healthcare 
===  =========================  ======================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  ======================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  =================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  ======================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  ======================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  =================================================================== 
 a)   Description of             American Depositary Shares ('ADSs') 
       the financial 
       instrument                 ISIN: US37733W1053 
===  =========================  ======================================== 
 b)   Nature of the             The vesting and release of ADSs awarded 
       transaction               in 2016 under the Company's 2009 Share 
                                 Value Plan. 
===  =========================  ======================================== 
 c)   Price(s) and                Price(s)    Volume(s) 
       volume(s)                              ---------- 
                                   n/a 
                                    .          11,212 
                                              ---------- 
===  =========================  ======================================== 
 d)   Aggregated information    n/a (single transaction) 
       Aggregated volume 
       Price 
===  =========================  ======================================== 
 e)   Date of the transaction   2019-02-11 
===  =========================  ======================================== 
 f)   Place of the              New York Stock Exchange (XNYS) 
       transaction 
===  =========================  ======================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ==================================================================== 
 a)   Name                     Mr B McNamara 
===  ========================  ========================================== 
 b)   Position/status          CEO, GSK Consumer Healthcare 
===  ========================  ========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ==================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ==================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial 
       instrument                ISIN: US37733W1053 
===  ========================  ========================================== 
 b)   Nature of the            The sale of ADSs to meet tax liabilities 
       transaction              further to the vesting and release of the 

                                2016 award under the Company's 2009 Share 
                                Value Plan. 
===  ========================  ========================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                            ---------- 
                                  $40.2654   5,522 
                                   . 
                                            ---------- 
===  ========================  ========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ========================================== 
 e)   Date of the transaction  2019-02-11 
===  ========================  ========================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  =========================================== 
 b)   Position/status          President, Pharma Supply Chain 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The vesting and release of Ordinary Shares 
       transaction              awarded in 2016 under the Company's 2009 
                                Share Value Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                  n/a         11,060 
                                             ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-02-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  ============================================== 
 b)   Position/status          President, Pharma Supply Chain 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  ============================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities further to the vesting and 
                                release of the 2016 award under the Company's 
                                2009 Share Value Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                  GBP15.5380    5,199 
                                               ---------- 
===  ========================  ============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-02-11 
===  ========================  ============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mrs V A Whyte 
===  ========================  =========================================== 
 b)   Position/status          Company Secretary 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            The vesting and release of Ordinary Shares 
       transaction              awarded in 2016 under the Company's 2009 
                                Share Value Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                  n/a         11,060 
                                             ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-02-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Mrs V A Whyte 
===  ========================  ============================================== 
 b)   Position/status          Company Secretary 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 

===  ========================  ============================================== 
 b)   Nature of the            The sale of Ordinary Shares to meet tax 
       transaction              liabilities further to the vesting and 
                                release of the 2016 award under the Company's 
                                2009 Share Value Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                  GBP15.5380    5,199 
                                               ---------- 
===  ========================  ============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-02-11 
===  ========================  ============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ==============================================

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHZLLFFKLFBBBL

(END) Dow Jones Newswires

February 12, 2019 09:03 ET (14:03 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Gsk.